Search results
Results From The WOW.Com Content Network
"Transfusion associated graft versus host disease" (PDF). Indian Pediatrics. 41 (12): 1260– 1264. PMID 15623910. Triulzi DJ (September 1992). "Transfusion associated graft vs. host disease and irradiated blood components". Archived from the original on 2006-07-22. Kardon E (8 July 2022). "Transfusion Reactions". EMedicine
Once a woman has antibodies, she is at high risk for a transfusion reaction. [36] For this reason, she must carry a medical alert card at all times and inform all doctors of her antibody status. [citation needed] "Acute hemolytic transfusion reactions may be either immune-mediated or nonimmune-mediated.
In transfusion medicine, transfusion-associated circulatory overload (aka TACO) is a transfusion reaction (an adverse effect of blood transfusion) resulting in signs or symptoms of excess fluid in the circulatory system (hypervolemia) within 12 hours after transfusion. [2]
The first treatment for Rh disease was an exchange transfusion invented by Wiener [24] and later refined by Dr. Harry Wallerstein. [25] Approximately 50,000 infants received this treatment. However, this could only treat the disease after it took root and did not do anything to prevent the disease.
Once a woman has antibodies, she is at high risk for a transfusion reaction. [42] For this reason, she must carry a medical alert card at all times and inform all doctors of her antibody status. [citation needed] "Acute hemolytic transfusion reactions may be either immune-mediated or nonimmune-mediated.
If a person without a Kidd blood antigen (for example a Jka-Jkb+ patient) receives a Kidd antigen (Jka-antigen for example) in a red blood cell transfusion and forms an alloantibody (anti-Jka); upon subsequent transfusion with Jka-antigen positive red blood cells, the patient may have a delayed hemolytic transfusion reaction as their anti-Jka antibody hemolyzes the transfused Jka-antigen ...
A British task force to establish transfusion guidelines for neonates and young children and to help try to explain this confusion recently concluded that “the optimal dose, timing, and nutritional support required during EPO treatment has yet to be defined and currently the routine use of EPO in this patient population is not recommended as ...
Blood compatibility testing is routinely performed before a blood transfusion.The full compatibility testing process involves ABO and RhD (Rh factor) typing; screening for antibodies against other blood group systems; and crossmatching, which involves testing the recipient's blood plasma against the donor's red blood cells as a final check for incompatibility.